| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.02 | 0.7 |